Skip to main content
Jiangsu Recbio Technology Co., Ltd. logo

Jiangsu Recbio Technology Co., Ltd. — Investor Relations & Filings

Ticker · 2179 ISIN · CNE1000057K9 LEI · 254900UBG3389KI4UR87 HKEX Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country CN China
Listing HKEX 2179

About Jiangsu Recbio Technology Co., Ltd.

http://www.recbio.cn

Jiangsu Recbio Technology Co., Ltd. is an innovative vaccine company focused on the research, development, and commercialization of subunit vaccines. The company leverages proprietary technology platforms, including novel adjuvant systems, protein engineering, and immune evaluation. Recbio is one of the few global entities capable of independently developing and manufacturing a full spectrum of novel vaccine adjuvants. The portfolio comprises over ten differentiated innovative vaccines targeting major diseases such as cervical cancer (HPV), herpes zoster (shingles), and respiratory syncytial virus (RSV). Key pipeline assets in China Phase III clinical studies include the recombinant 9-valent HPV vaccine (REC603) and the novel adjuvant recombinant herpes zoster vaccine (REC610). Manufacturing facilities are designed to comply with WHO PQ and EU GMP standards, supporting clinical supply and future commercialization, notably including a high-capacity facility for the 9-valent HPV vaccine.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report concerning movements in securities, specifically share capital and issued shares, for Jiangsu Recbio Technology Co., Ltd. It includes data on authorized and issued shares, treasury shares, public float sufficiency confirmation, and confirmations related to compliance with listing rules. The document is addressed to the Hong Kong Exchanges and Clearing Limited and references specific listing rules and regulatory requirements. It is a regulatory submission reporting share capital changes and compliance confirmations rather than a financial report, earnings release, or management discussion. It is not an announcement of a report publication but a substantive regulatory filing. Therefore, the document fits best under the category of Regulatory Filings (RNS).
2026-05-05 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 100% confidence The document is a Next Day Disclosure Return related to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It details specific changes in share capital, including conversions and changes in issued shares, with dates and percentages. The document references compliance with listing rules and confirms authorization by the board of directors. It is a regulatory disclosure about share capital changes rather than a financial report, earnings release, or management discussion. The document is not a full report but a regulatory filing required by the stock exchange rules to disclose share capital changes. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2026-04-30 English
INSIDE INFORMATION ANNOUNCEMENT COMPLETION OF FULL CIRCULATION OF H SHARES
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Jiangsu Recbio Technology Co., Ltd. regarding the completion of the full circulation of H shares, including details about the conversion of unlisted shares into H shares and the updated shareholding structure. It references prior announcements and regulatory approvals but does not contain financial statements or detailed financial analysis. The document is relatively short (3540 characters) and serves as an official notice of a capital structure change related to share listing and circulation. This fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other types of filings.
2026-04-30 English
Form of Proxy for use at the 2025 Annual General Meeting to be held on Thursday, May 28, 2026
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a Form of Proxy for the 2025 Annual General Meeting, providing instructions for shareholders to appoint proxies and vote on specified resolutions. It is not financial results, a report itself, or a simple announcement but a solicitation of shareholder proxies. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-29 English
NOTICE OF 2025 ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a formal Notice of 2025 Annual General Meeting, setting out the date, venue and resolutions to be voted on and instructions on proxy appointment. It is sent to shareholders to provide information and solicit votes ahead of the meeting. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI). It is not the AGM materials themselves (AGM-R) nor a simple regulatory announcement (RNS).
2026-04-29 English
CIRCULAR OF 2025 ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a detailed circular from Jiangsu Recbio Technology Co., Ltd. regarding the upcoming 2025 Annual General Meeting (AGM) scheduled for May 28, 2026. It includes the notice of the AGM, proxy information, and detailed descriptions of the agenda items to be considered and approved at the AGM, such as the 2025 Financial Accounts Report, 2026 Financial Budget Report, 2025 Work Report of the Board of Directors, 2025 Annual Report, engagement of auditors, remuneration scheme for directors, profit distribution plan, and proposed change of use of proceeds. The document is not the actual annual report or financial statements but a circular providing information for shareholders to make informed decisions at the AGM. It also includes the notice of the AGM itself and proxy forms. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting. The document length is substantial (15,000 characters), indicating it is not a mere announcement but a full circular related to the AGM. Therefore, the correct classification is AGM Information (AGM-R).
2026-04-29 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.